FHC
BPMC

First Horizon Corporation’s Blueprint Medicines BPMC Stock Holding History

First Horizon Corporation’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$6K Hold
76
– – ﹤0.01% 804
2021
Q1 		$7K Sell
76
-2
-3% -$200 ﹤0.01% 757
2020
Q4 		$8K Sell
78
-12
-13% -$1.26K ﹤0.01% 688
2020
Q3 		$8K Buy
+90
New +$6.93K ﹤0.01% 658

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

First Horizon Corporation's BPMC Position: Q2 2021 in Review

First Horizon Corporation held its Blueprint Medicines (BPMC) position steady in Q2 2021 at 76 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #804.

First Horizon Corporation first reported a position in BPMC in Q3 2020 and has held it in 4 quarters since. The position peaked at $8K in Q4 2020. 281 funds tracked by Wall St. Rank hold BPMC as of Q2 2021.

  • First Horizon Corporation held 76 shares of Blueprint Medicines worth $6K as of Q2 2021.
  • First Horizon Corporation left its Blueprint Medicines share count unchanged in Q2 2021.
  • Blueprint Medicines made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #804 holding.
  • First Horizon Corporation first reported a position in Blueprint Medicines in Q3 2020 and has held it in 4 quarters since.
  • First Horizon Corporation's Blueprint Medicines position peaked at $8K in Q4 2020.
  • 281 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.